Compare USEG & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USEG | ZYXI |
|---|---|---|
| Founded | 1966 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.1M | 35.8M |
| IPO Year | N/A | N/A |
| Metric | USEG | ZYXI |
|---|---|---|
| Price | $0.98 | $0.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $3.50 | $3.00 |
| AVG Volume (30 Days) | 248.9K | ★ 14.6M |
| Earning Date | 11-12-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $9,484,000.00 | ★ $108,202,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $57.52 | $9.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.94 | $0.38 |
| 52 Week High | $6.40 | $8.72 |
| Indicator | USEG | ZYXI |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 43.40 |
| Support Level | $0.99 | $0.75 |
| Resistance Level | $1.05 | $0.95 |
| Average True Range (ATR) | 0.05 | 0.28 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 29.46 | 10.20 |
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.